Protara Therapeutics, Inc.TARANASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+36.4%
5Y CAGR+29.1%
Year-over-Year Change
Research and development spending
3Y CAGR
+36.4%/yr
vs +2.0%/yr prior
5Y CAGR
+29.1%/yr
Recent acceleration
Acceleration
+34.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $42.63M | +34.5% |
| 2024 | $31.70M | +27.9% |
| 2023 | $24.79M | +47.5% |
| 2022 | $16.81M | -20.3% |
| 2021 | $21.09M | +77.5% |
| 2020 | $11.88M | +84.6% |
| 2019 | $6.44M | -58.5% |
| 2018 | $15.51M | -28.5% |
| 2017 | $21.69M | +14.9% |
| 2016 | $18.87M | - |